Group 135
vector-clinical-hero

A glance at our journey to fight cancer

About-new
New-office

Imagene AI was founded in 2020 with a clear mission to empower physicians and researchers with immediate oncology intelligence to facilitate optimal treatment for more cancer patients.
Harnessing the power of biopsy images to unlock groundbreaking insights, we are transforming cancer diagnostics and research with AI-powered precision oncology.
FoundationOI, our revolutionary Vision Foundation Model, enables the versatile development of applications within the cancer domain including treatment responses, disease prognosis, and novel biomarker discovery.
LungOI, the first AI-based NSCLC biomarker test, provides rapid and accurate biomarker profiling, facilitating timely and informed clinical decisions.
Imagene was recognized by Frost & Sullivan for the 2023 "Technology Innovation Leadership Award in AI-based molecular testing for cancer diagnosis" and won the 2023 Digital Health Award for "Best use of AI." Our success derives from our cutting-edge technology and a multidisciplinary team of data scientists, biologists, software engineers, and medical experts.

Founding Team

Dean
Dean Bitan
CEO & Co-Founder
John
Jonathan Zalach
CDS & Co-Founder
Shahar
Shahar Porat
CTO & Co-Founder
bg-about-management

Join our Partners

logo-partners-2 logo-partners-1 logo-partners-3
Learn More About Us
vector-jhome-partners-1
vector-jhome-partners-2

Board of Directors

Yodfat-Harel-Buchris

Yodfat Harel Buchris

Dr

Dr. David Agus

Eyal-Gura

Eyal Gura

Dean_600

Dean Bitan

John_600

Jonathan Zalach